{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:54:20Z","timestamp":1766516060815},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,17]]},"DOI":"10.7759\/cureus.39145","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T18:53:30Z","timestamp":1684349610000},"source":"Crossref","is-referenced-by-count":3,"title":["Helicobacter Pylori-Associated Gastritis in Middle Eastern Patients: A Case Series"],"prefix":"10.7759","author":[{"given":"Zahid","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amresh","family":"Gul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2016.1178065","article-title":"Helicobacter pylori therapy: a paradigm shift","volume":"14","author":"Graham DY","year":"2016","unstructured":"Graham DY, Dore MP. Helicobacter pylori therapy: a paradigm shift. Expert Rev Anti Infect Ther. 2016, 14:577-85. 10.1080\/14787210.2016.1178065","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/2050640615617358","article-title":"Systematic review and meta-analysis: multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events","volume":"4","author":"McFarland LV","year":"2016","unstructured":"McFarland LV, Huang Y, Wang L, Malfertheiner P. Systematic review and meta-analysis: multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events. United European Gastroenterol J. 2016, 4:546-61. 10.1177\/2050640615617358","journal-title":"United European Gastroenterol J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/jms.jms_25_17","article-title":"World Health Organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics","volume":"32","author":"Shrivastava SR","year":"2018","unstructured":"Shrivastava SR, Shrivastava PS, Ramasamy J. World Health Organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. J Med Soc. 2018, 32:76-7. 10.4103\/jms.jms_25_17","journal-title":"J Med Soc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36041","article-title":"From antibiotic resistance to antibiotic renaissance: a new era in Helicobacter pylori treatment","volume":"15","author":"Godavarthy PK","year":"2023","unstructured":"Godavarthy PK, Puli C. From antibiotic resistance to antibiotic renaissance: a new era in Helicobacter pylori treatment. Cureus. 2023, 15:e36041. 10.7759\/cureus.36041","journal-title":"Cureus"},{"key":"ref5","article-title":"Helicobacter pylori eradication - an update on the latest therapies","volume":"43","author":"Yaxley J","year":"2014","unstructured":"Yaxley J, Chakravarty B. Helicobacter pylori eradication - an update on the latest therapies. Aust Fam Physician. 2014, 43:301-5.","journal-title":"Aust Fam Physician"},{"key":"ref6","article-title":"Helicobacter pylori--the latest in diagnosis and treatment","volume":"37","author":"Stenstr\u00f6m B","year":"2008","unstructured":"Stenstr\u00f6m B, Mendis A, Marshall B. Helicobacter pylori--the latest in diagnosis and treatment. Aust Fam Physician. 2008, 37:608-12.","journal-title":"Aust Fam Physician"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9082716","article-title":"Living conditions and Helicobacter pylori in adults","volume":"2017","author":"Amaral O","year":"2017","unstructured":"Amaral O, Fernandes I, Veiga N, Pereira C, Chaves C, Nelas P, Silva D. Living conditions and Helicobacter pylori in adults. Biomed Res Int. 2017, 2017:9082716. 10.1155\/2017\/9082716","journal-title":"Biomed Res Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03846.x","article-title":"Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patients","volume":"28","author":"Vakil N","year":"2008","unstructured":"Vakil N, Zullo A, Ricci C, Hassan C, Vaira D. Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patients. Aliment Pharmacol Ther. 2008, 28:1304-8. 10.1111\/j.1365-2036.2008.03846.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2005.10.022","article-title":"Is there any correlation between 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies?","volume":"38","author":"Gisbert JP","year":"2006","unstructured":"Gisbert JP, Olivares D, Jimenez I, Pajares JM. Is there any correlation between 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies?. Dig Liver Dis. 2006, 38:254-9. 10.1016\/j.dld.2005.10.022","journal-title":"Dig Liver Dis"},{"key":"ref10","article-title":"Helicobacter pylori: the Middle East scenario","volume":"71","author":"Novis BH","year":"1998","unstructured":"Novis BH, Gabay G, Naftali T. Helicobacter pylori: the Middle East scenario. Yale J Biol Med. 1998, 71:135-41.","journal-title":"Yale J Biol Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56040169","article-title":"Prevalence of Helicobacter pylori infection and diagnostic methods in the Middle East and North Africa region","volume":"56","author":"Alsulaimany FA","year":"2020","unstructured":"Alsulaimany FA, Awan ZA, Almohamady AM, Koumu MI, Yaghmoor BE, Elhady SS, Elfaky MA. Prevalence of Helicobacter pylori infection and diagnostic methods in the Middle East and North Africa region. Medicina (Kaunas). 2020, 56:3-7. 10.3390\/medicina56040169","journal-title":"Medicina (Kaunas)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i46.17618","article-title":"Epidemiology of Helicobacter pylori infection among the healthy population in Iran and countries of the Eastern Mediterranean region: a systematic review of prevalence and risk factors","volume":"20","author":"Eshraghian A","year":"2014","unstructured":"Eshraghian A. Epidemiology of Helicobacter pylori infection among the healthy population in Iran and countries of the Eastern Mediterranean region: a systematic review of prevalence and risk factors. World J Gastroenterol. 2014, 20:17618-25. 10.3748\/wjg.v20.i46.17618","journal-title":"World J Gastroenterol"},{"key":"ref13","article-title":"Prevalence of Helicobacter pylori infection among patients with dyspepsia in South-Western Saudi Arabia","volume":"25","author":"Ayoola AE","year":"2004","unstructured":"Ayoola AE, Ageely HM, Gadour MO, Pathak VP. Prevalence of Helicobacter pylori infection among patients with dyspepsia in South-Western Saudi Arabia. Saudi Med J. 2004, 25:1433-8.","journal-title":"Saudi Med J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/157869-helicobacter-pylori-associated-gastritis-in-middle-eastern-patients-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:02:04Z","timestamp":1707508924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/157869-helicobacter-pylori-associated-gastritis-in-middle-eastern-patients-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,17]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.39145","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,17]]}}}